Flow cytometry (FCM), next-generation sequencing, (NGS), and polymerase chain reaction (PCR) are the 3 most common methods clinicians use to diagnose minimal residual disease (MRD) in patients with ...

The mechanisms of resistance to immunotherapies in patients with acute myeloid leukemia (AML) are not well-characterized, and biomarkers for improved immunotherapeutic strategies are critical. In this ...

In this three-part webinar series, we invite you to explore the benefits of a standardized workflow in leukemia and lymphoma analysis. Join this showcase of Beckman Coulter’s new DxFLEX flow cytometer ...

For example, flow cytometry can distinguish different cellular properties from morphology to cell cycle stage. Furthermore, the information provided by a flow cytometer reflects the individual cells ...

A series of blood tests, procedures, and imaging tests can help diagnose acute myeloid leukemia (AML). Additionally, these tests can also determine its subtype and help identify the best treatment ...

Immunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases. Immunophenotyping is a lab test doctors use to identify and ...

Leukemia is a type of cancer that starts in immature blood cells in the bone marrow. Doctors typically use blood tests alongside other medical tools to diagnose leukemia. Most leukemias begin in cells ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Dr Radich is a ...

To schedule time for flow analysis, call 977-8877. Leave a message if you are unable to reach us immediately and we will return your call as soon as possible. Users are also welcome to stop by the ...